ALCOA+ and Data Integrity

Data supporting the quality and safety of product must meet the ALCOA+ elements in order to avoid regulatory citations for data integrity issues.

Read this article in Pharmaceutical Technology’s March 2020 Regulatory Sourcebook.

Article Details

Pharmaceutical Technology
eBook: Regulatory Sourcebook, March 2020
March 2020
Pages: 10–13

Citation

When referring to this article, please cite it as S. J. Schniepp, “ALCOA+ and Data Integrity," Pharmaceutical Technology Regulatory Sourcebook eBook (March 2020).

Articles in this issue

over 5 years ago

Article

Resources, Guidelines, and Guidance Documents

over 5 years ago

Article

Regulatory and Standard Setting Organizations

over 5 years ago

Article

A ‘New Normal’ for Quality?

over 5 years ago

Article

Monograph Development: Why and When to Participate (eBook)

over 5 years ago

Article

Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon (eBook)

over 5 years ago

Article

A Practical Approach to Pharmacopoeia Compliance (eBook)

over 5 years ago

Article

Inside FDA’s New Gene and Cell Therapy Guidances

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!